Related Experiment Video
Updated: Feb 5, 2026

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
Published on: March 14, 2014
New developments in mechanisms of prostate cancer progression
Nicholas Howard1, Marco Clementino1, Donghern Kim1
1Department of Toxicology and Cancer Biology, United States.
Abstract:
Prostate cancer is the most prevalent type of cancer in men. The etiology of prostate cancer development and the mechanisms underlying androgen-independent progression remains to be further investigated. There are many known targets for prostate cancer therapy including the androgen receptor (AR) axis, but resistance eventually develops in advanced disease suggesting the need to better understand mechanisms of resistance and consideration of multi-targeted therapy. Mechanisms contributing to resistance may include gene amplifications, gene mutations, AR splice variants, and changes in expression of androgen receptor co-regulatory proteins. Given the limitations of approved therapies, further study of additional potential targets is warranted. This review focuses on the roles of autophagy pathway, p62, Yes-associated protein (YAP), cancer stem cells, and epigenetics. Therapies targeting these potential mechanisms of resistance may interact with currently approved therapies either additively or synergistically. Thus, the study of combination therapy against multiple targets may be critically important to achieve more impact against lethal forms of prostate cancer resistant to all approved current therapies.
Insights
Prostate cancer therapy faces resistance due to complex mechanisms. Targeting pathways like autophagy and epigenetics offers new hope for treating advanced, lethal prostate cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Prostate cancer is the most common cancer in men.
- Androgen receptor (AR) targeted therapies are standard but face resistance in advanced disease.
- Mechanisms of resistance include genetic alterations and AR splice variants.
Purpose of the Study:
- To review emerging therapeutic targets for prostate cancer.
- To explore mechanisms of resistance to current therapies.
- To highlight the potential of combination therapies for lethal prostate cancer.
Main Methods:
- Literature review focusing on novel therapeutic targets.
- Analysis of resistance mechanisms in prostate cancer progression.
- Discussion of potential synergistic effects of combination therapies.
Main Results:
- Identified key pathways involved in resistance: autophagy, p62, YAP, cancer stem cells, and epigenetics.
- Highlighted the limitations of current single-target therapies.
- Emphasized the potential for novel therapies to overcome resistance.
Conclusions:
- Further investigation into novel targets like autophagy and epigenetics is crucial.
- Combination therapies targeting multiple pathways may improve outcomes for resistant prostate cancer.
- Understanding resistance mechanisms is key to developing more effective treatments.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mechanisms of Retrovirus-induced Cancers
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Reaction Mechanisms
For instance, the decomposition of ozone appears to follow a mechanism with two steps:
Mechanical Protein Functions

